Schwencke, Carsten, Bijuklic, Klaudija, Ouarrak, Taoufik, Lubos, Edith, Schillinger, Wolfgang, Plicht, Bjoern ORCID: 0000-0002-9581-3121, Eggebrecht, Holger, Baldus, Stephan, Schymik, Gerhard, Boekstegers, Peter, Hoffmann, Rainer, Senges, Jochen and Schofer, Joachim (2017). Impact of cardiac comorbidities on early and 1-year outcome after percutaneous mitral valve interventions: data from the German transcatheter mitral valve interventions (TRAMI) registry. Clin. Res. Cardiol., 106 (4). S. 249 - 259. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1861-0692

Full text not available from this repository.

Abstract

The use of the MitraClip system has gained widespread acceptance for the treatment of patients with mitral regurgitation (MR) who are not suitable for the conventional surgery. This study sought to investigate the early and 1-year outcome after MitraClip therapy of patients with MR and cardiac comorbidities. Outcomes through 12-month follow-up of patients (n = 528) who underwent MitraClip implantation were obtained from the German transcatheter mitral valve interventions (TRAMI) registry. The majority of these patients (n = 409, 77.5 %) also suffered from coronary artery disease (CAD). Patients with a dilated cardiomyopathy (DCM, n = 65, 12.3 %) or concomitant valvular aortic disease (AV, n = 54, 10.2 %) were less frequent. Although the prevalent pathogenesis was functional MR, patients with DCM had significantly more frequent a functional MR (96.9 %) compared to patients with CAD (74.9 %) or AV (62.5 %, p < 0.001). Technical success was achieved in 97.5 % of patients. Procedural echocardiograms demonstrated in the vast majority of patients a reduction from severe MR III to mild MR I with no difference between the groups (p = 0.83). The peri-procedural complication rate was very low. At 30-day and 12-month follow-up, the majority of patients were in NYHA functional class II or lower. The rate of death, stroke, and myocardial infarction (MACCE) was comparable in the three patient groups during 12-month follow-up (DCM 26.9 %, CAD 30.3 % and AV 27.5 %, p = 0.85). The MitraClip implantation is feasible and safe even in high-risk patients with MR and cardiac comorbidities.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Schwencke, CarstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bijuklic, KlaudijaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ouarrak, TaoufikUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lubos, EdithUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schillinger, WolfgangUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Plicht, BjoernUNSPECIFIEDorcid.org/0000-0002-9581-3121UNSPECIFIED
Eggebrecht, HolgerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baldus, StephanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schymik, GerhardUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boekstegers, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoffmann, RainerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Senges, JochenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schofer, JoachimUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-235281
DOI: 10.1007/s00392-016-1044-3
Journal or Publication Title: Clin. Res. Cardiol.
Volume: 106
Number: 4
Page Range: S. 249 - 259
Date: 2017
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1861-0692
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ACADEMIC RESEARCH CONSORTIUM; LEFT-VENTRICULAR DYSFUNCTION; TRIAL DESIGN PRINCIPLES; END-POINT DEFINITIONS; HIGH-SURGICAL-RISK; TO-EDGE REPAIR; CONSENSUS DOCUMENT; GENERAL-ANESTHESIA; HEART-FAILURE; REGURGITATIONMultiple languages
Cardiac & Cardiovascular SystemsMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/23528

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item